+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Tibet Pharmaceuticals

TBETOTCEM

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$~0

00.00%

Pre-Market: Dec 6, 5:25 PM EDT

15 minutes delayed

Tibet Pharmaceuticals (TBET) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Tibet Pharmaceuticals (OTC:TBET) Stock

Tibet Pharmaceuticals Stock (OTC: TBET)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, March 08, 2012

Benzinga's Microcap Movers for Wednesday March 7, 2012
Benzinga

Thursday, March 01, 2012

Tibet Pharmaceuticals, Inc. Announces Receipt of Non-Binding "Going Private" Proposal at $3.00 Per Share
Benzinga

Monday, February 27, 2012

Benzinga's M&A Chatter for Monday February 27, 2012
Benzinga
Tibet Pharmaceuticals Announces Intent to Go Private
Benzinga

Tuesday, January 31, 2012

Tibet Pharmaceuticals Signs Letter of Intent to Cooperate With Anhui Taihe Pharmaceutical Group
Benzinga

Tuesday, October 18, 2011

Tibet Pharmaceuticals Announces Appointment of Sherb & Co., LLP as New Independent Auditor
Benzinga

Tuesday, September 20, 2011

Morning Market Movers
Benzinga

Tuesday, September 13, 2011

NASDAQ Scheduled Resumption in Tibet Pharmaceuticals for 1:30 PM
Benzinga

Monday, September 12, 2011

Tibet Pharmaceuticals Announces Search for New Auditor Upon Resignation of ACSB
Benzinga
Tibet Pharma Halted
Benzinga

Wednesday, June 29, 2011

Morning Market Losers
Benzinga

Friday, June 10, 2011

Tibet Pharmaceuticals Announces New CEO
Benzinga

Tuesday, April 19, 2011

Murphy Analytics Initiates Research Coverage on Tibet Pharmaceuticals (TBET)
Benzinga

Monday, January 24, 2011

Tibet Pharmaceuticals Announces Closing of IPO
Benzinga

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved